Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Prognostic factors of non-muscle invasive bladder cancer: a study based on next-generation sequencing

Fig. 1

Oncoprint of genetic pathways. BCG: Bacillus Calmette–Guérin treated group; EPI: epirubicin treated group. CUETO model: Spanish Urological Club for Oncological Treatment scoring model; EORTC: European Organization for Research and Treatment of Cancer; CN: copy number; RTK: receptor tyrosine kinases; PI3K: phosphatidylinositol 3-kinase; SWI/SNF: Switch/sucrose nonfermentable

Back to article page